Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Asset Utilization Ratio of 0.0 in Q2 2022, down 52.38% quarter-over-quarter from 0.0 in Q1 2022, and down 96.18% on a YoY basis from 0.03 in Q2 2021.

Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022) Analysis & Trends

Corbus Pharmaceuticals Holdings' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q2 2022.

  • In Q2 2022, Asset Utilization Ratio fell 96.18% year-over-year to 0.0; the TTM figure through Jun 2022 stood at 0.0 (down 96.18% YoY), while the FY2021 annual figure was 0.01, down 87.29% from the prior year.
  • Asset Utilization Ratio was 0.0 for Q2 2022 at Corbus Pharmaceuticals Holdings, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.44 in Q3 2019 to a low of 0.29 in Q2 2020.
  • Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2018.
  • The sharpest annual moves came in 2019 and 2020: Asset Utilization Ratio jumped 907.31% in 2019, then plunged 184.23% in 2020.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2018, then surged by 48.97% to 0.09 in 2019, then plunged by 40.81% to 0.05 in 2020, then sank by 84.63% to 0.01 in 2021, then sank by 85.88% to 0.0 in 2022.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2022), 0.0 (Q1 2022), and 0.01 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 0.55
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 1,422.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.47
9 Abivax 94.37 Bn 94.37 Bn - -
10 Corbus Pharmaceuticals Holdings 133.67 Mn 105.86 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Sep 30, 2021 0.02
Jun 30, 2021 0.03
Mar 31, 2021 0.03
Dec 31, 2020 0.05
Sep 30, 2020 -0.26
Jun 30, 2020 -0.29
Mar 31, 2020 0.09
Dec 31, 2019 0.09
Sep 30, 2019 0.44
Jun 30, 2019 0.35
Mar 31, 2019 0.05
Dec 31, 2018 0.06
Sep 30, 2018 0.04
Jun 30, 2018 0.04
Mar 31, 2018 0.03
Dec 31, 2017 0.05
Sep 30, 2017 0.08